Fewer revisit it before adding a provider, expanding services, or opening a second location
Were looking at diabetes, strokes, heart attacks, fatty liver disease. type 2 diabetes In the same KFF poll, among the states that do cover the drugs, the most popular reason given for doing so was positive health outcomes and longer-term savings, followed by enrollee access and health equity. Both Martin and Makowicki continue to experience these types of positive health outcomes a few years into using GLP-1s
prescription, accepts payment only in cryptocurrency, or labels its vials "research chemical, not for human use." Prices that sit far below every licensed pharmacy, the absence of a reachable pharmacist, and no requirement for a clinical review are each signals that the product may be counterfeit, mislabeled, or non-sterile
Saving the setup in PepSync helps avoid re-entering the same details each week
These are not complicated changes but they do need to be intentional
